Literature DB >> 17428869

Construction and characterization of a full-length infectious simian T-cell lymphotropic virus type 3 molecular clone.

Sébastien Alain Chevalier1, Marine Walic, Sara Calattini, Adeline Mallet, Marie-Christine Prévost, Antoine Gessain, Renaud Mahieux.   

Abstract

Together with their simian T-cell lymphotropic virus (STLV) equivalent, human T-cell lymphotropic virus type 1 (HTLV-1), HTLV-2, and HTLV-3 form the primate T-cell lymphotropic virus (PTLV) group. Over the years, understanding the biology and pathogenesis of HTLV-1 and HTLV-2 has been widely improved by the creation of molecular clones. In contrast, so far, PTLV-3 experimental studies have been restricted to the overexpression of the tax gene using reporter assays. We have therefore decided to construct an STLV-3 molecular clone. We generated a full-length STLV-3 proviral clone (8,891 bp) by PCR amplification of overlapping fragments. This STLV-3 molecular clone was then transfected into 293T cells. Reverse transcriptase PCR experiments followed by sequence analysis of the amplified products allowed us to establish that both gag and tax/rex mRNAs were transcribed. Western blotting further demonstrated the presence of the STLV-3 p24gag protein in the cell culture supernatant from transfected cells. Transient transfection of 293T cells and of 293T-long terminal repeat-green fluorescent protein cells with the STLV-3 clone promoted syncytium formation, a hallmark of PTLV Env expression, as well as the appearance of fluorescent cells, also demonstrating that the Tax3 protein was expressed. Virus particles were visible by electron microscopy. These particles are infectious, as demonstrated by our cell-free-infection experiments with purified virions. All together, our data demonstrate that the STLV-3 molecular clone is functional and infectious. This clone will give us a unique opportunity to study in vitro the different pX transcripts and the putative presence of antisense transcripts and to evaluate the PTLV-3 pathogenicity in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17428869      PMCID: PMC1900091          DOI: 10.1128/JVI.02538-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  68 in total

1.  DC-SIGN facilitates fusion of dendritic cells with human T-cell leukemia virus type 1-infected cells.

Authors:  Pierre-Emmanuel Ceccaldi; Frédéric Delebecque; Marie-Christine Prevost; Arnaud Moris; Jean-Pierre Abastado; Antoine Gessain; Olivier Schwartz; Simona Ozden
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

2.  Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo.

Authors:  J T Bartoe; B Albrecht; N D Collins; M D Robek; L Ratner; P L Green; M D Lairmore
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Construction of infectious feline foamy virus genomes: cat antisera do not cross-neutralize feline foamy virus chimera with serotype-specific Env sequences.

Authors:  M Zemba; A Alke; J Bodem; I G Winkler; R L Flower; K Pfrepper; H Delius; R M Flügel; M Löchelt
Journal:  Virology       Date:  2000-01-05       Impact factor: 3.616

4.  Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sézary T-cell leukaemia.

Authors:  B J Poiesz; F W Ruscetti; M S Reitz; V S Kalyanaraman; R C Gallo
Journal:  Nature       Date:  1981-11-19       Impact factor: 49.962

5.  Nucleotide sequence analysis of the long terminal repeat of human T-cell leukemia virus type II.

Authors:  K Shimotohno; D W Golde; M Miwa; T Sugimura; I S Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

6.  Molecular characterization of genome of a novel human T-cell leukaemia virus.

Authors:  I S Chen; J McLaughlin; J C Gasson; S C Clark; D W Golde
Journal:  Nature       Date:  1983 Oct 6-12       Impact factor: 49.962

7.  Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivo.

Authors:  Hajime Hiraragi; Seung-Jae Kim; Andrew J Phipps; Micol Silic-Benussi; Vincenzo Ciminale; Lee Ratner; Patrick L Green; Michael D Lairmore
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

8.  A 10-amino acid domain within human T-cell leukemia virus type 1 and type 2 tax protein sequences is responsible for their divergent subcellular distribution.

Authors:  Laurent Meertens; Sébastien Chevalier; Robert Weil; Antoine Gessain; Renaud Mahieux
Journal:  J Biol Chem       Date:  2004-07-21       Impact factor: 5.157

9.  Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA.

Authors:  M Seiki; S Hattori; Y Hirayama; M Yoshida
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

10.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  9 in total

1.  Emergence of a novel and highly divergent HTLV-3 in a primate hunter in Cameroon.

Authors:  HaoQiang Zheng; Nathan D Wolfe; David M Sintasath; Ubald Tamoufe; Matthew Lebreton; Cyrille F Djoko; Joseph Le Doux Diffo; Brian L Pike; Walid Heneine; William M Switzer
Journal:  Virology       Date:  2010-03-30       Impact factor: 3.616

2.  Hyperediting of human T-cell leukemia virus type 2 and simian T-cell leukemia virus type 3 by the dsRNA adenosine deaminase ADAR-1.

Authors:  Nga Ling Ko; Emmanuel Birlouez; Simon Wain-Hobson; Renaud Mahieux; Jean-Pierre Vartanian
Journal:  J Gen Virol       Date:  2012-09-19       Impact factor: 3.891

3.  Discovery and characterization of auxiliary proteins encoded by type 3 simian T-cell lymphotropic viruses.

Authors:  Jocelyn Turpin; Chloé Journo; Nga Ling Ko; Flore Sinet; Alexandre Carpentier; Amandine Galioot; Dustin Edwards; Anne-Mieke Vandamme; Louis Gazzolo; Madeleine Duc Dodon; Antoine Gessain; Fatah Kashanchi; Ivan Balansard; Romain Lacoste; Renaud Mahieux
Journal:  J Virol       Date:  2014-10-29       Impact factor: 5.103

4.  One-step, multiplex, real-time PCR assay with molecular beacon probes for simultaneous detection, differentiation, and quantification of human T-cell leukemia virus types 1, 2, and 3.

Authors:  Guillaume Besson; Mirdad Kazanji
Journal:  J Clin Microbiol       Date:  2009-02-11       Impact factor: 5.948

5.  The receptor complex associated with human T-cell lymphotropic virus type 3 (HTLV-3) Env-mediated binding and entry is distinct from, but overlaps with, the receptor complexes of HTLV-1 and HTLV-2.

Authors:  Kathryn S Jones; Ying K Huang; Sébastien A Chevalier; Philippe V Afonso; Cari Petrow-Sadowski; Daniel C Bertolette; Antoine Gessain; Francis W Ruscetti; Renaud Mahieux
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

6.  Construction and characterization of a human T-cell lymphotropic virus type 3 infectious molecular clone.

Authors:  Sébastien Alain Chevalier; Nga Ling Ko; Sara Calattini; Adeline Mallet; Marie-Christine Prévost; Kylene Kehn; John N Brady; Fatah Kashanchi; Antoine Gessain; Renaud Mahieux
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

7.  Ancient, independent evolution and distinct molecular features of the novel human T-lymphotropic virus type 4.

Authors:  William M Switzer; Marco Salemi; Shoukat H Qari; Hongwei Jia; Rebecca R Gray; Aris Katzourakis; Susan J Marriott; Kendle N Pryor; Nathan D Wolfe; Donald S Burke; Thomas M Folks; Walid Heneine
Journal:  Retrovirology       Date:  2009-02-02       Impact factor: 4.602

8.  Alteration of blood-brain barrier integrity by retroviral infection.

Authors:  Philippe V Afonso; Simona Ozden; Marie-Christine Cumont; Danielle Seilhean; Luis Cartier; Payam Rezaie; Sarah Mason; Sophie Lambert; Michel Huerre; Antoine Gessain; Pierre-Olivier Couraud; Claudine Pique; Pierre-Emmanuel Ceccaldi; Ignacio A Romero
Journal:  PLoS Pathog       Date:  2008-11-14       Impact factor: 6.823

Review 9.  HTLV-3/4 and simian foamy retroviruses in humans: discovery, epidemiology, cross-species transmission and molecular virology.

Authors:  Antoine Gessain; Réjane Rua; Edouard Betsem; Jocelyn Turpin; Renaud Mahieux
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.